BMJ1d
Time to steroids impacts visual outcome of optic neuritis in MOGAD
Background To characterise the response to treatment of inaugural optic neuritis (ON) in patients with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). Methods We searched the ...
BMJ1d
Are men at greater risk for Parkinson’s disease than women?
1 Department of Neurology, University of Virginia School of Medicine, Charlottesville, USA 2 Department of Health Evaluation Sciences, University of Virginia School of Medicine Correspondence to: Dr G ...
BMJ2d
Range of neuropsychiatric disturbances in patients with Parkinson’s disease
Dr Dag Aarsland, Section of Geriatric Psychiatry, Rogaland Psychiatric Hospital, PO Box 1163, Hillevåg, N-4004 Stavanger, Norway. Telephone 0047 51515151; fax 0047 51515075; email aarsland{at}netpower ...
BMJ3d
Deep brain stimulation activation volumes and their association with neurophysiological mapping and therapeutic outcomes
Dr C C McIntyre, Department of Biomedical Engineering, Cleveland Clinic Foundation, 9500 Euclid Ave ND20, Cleveland, OH 44195, USA; mcintyc{at}ccf.org Objective: Despite the clinical success of deep ...
BMJ4d
Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker
Background: Neuromyelitis optica (NMO) is a neurological inflammatory disease associated with autoimmunity to aquaporin 4, predominantly localised in astrocytic foot processes. Recent studies have ...
BMJ5d
Silent progression of brain atrophy in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder
Correspondence to Dr Masahiro Mori, Neurology, Chiba University Graduate School of Medicine School of Medicine, Chiba, Chiba, Japan; morim{at}faculty.chiba-u.jp Objective To investigate longitudinal ...
BMJ1d
010 Seizure semiology of frontal lobe epilepsy (FLE): a report of two cases with video-telemetry recordings
Frontal lobe seizures can be difficult to distinguish from non-epileptic seizures or sleep disorders. Addition- ally, the ictal EEG is often normal. To illustrate the challenging semiology and ...
BMJ3d
Ultra-high-dose methylcobalamin in amyotrophic lateral sclerosis: a long-term phase II/III randomised controlled study
Objective To evaluate the efficacy and safety of intramuscular ultra-high-dose methylcobalamin in patients with amyotrophic lateral sclerosis (ALS). Methods 373 patients with ALS (El Escorial definite ...
BMJ3d
Early weight loss in amyotrophic lateral sclerosis: outcome relevance and clinical correlates in a population-based cohort
Objectives To assess the role of body mass index (BMI) and of the rate of weight loss as prognostic factors in amyotrophic lateral sclerosis (ALS) and to explore the clinical correlates of weight loss ...
BMJ2d
Unilateral lenticular infarcts: radiological and clinical syndromes, aetiology, and prognosis
Service de Neurologie, Centre Hospitalo-Universitaire, 3 Rue du Faubourg, Raines, 21000 Dijon, France Professor M Giroud, Service de Neurologie, Centre Hospitalo-Universitaire, 3 Rue du Faubourg, ...
BMJ3d
Tumefactive demyelination: an approach to diagnosis and management
2 Queen Square MS Centre, Institute of Neurology, University College London, London, UK Correspondence to Dr Todd Hardy, Box 21, National Hospital for Neurology and Neurosurgery, Queen Square, London ...
BMJ8d
Bladder dysfunction in hereditary spastic paraplegia: what to expect?
Correspondence to Dr M Braschinsky, Department of Neurology, University of Tartu, Puusepa 2, Tartu 51014, Estonia; mark.braschinsky{at}kliinikum.ee Background Hereditary spastic paraplegia (HSP) ...